A Prospective, Multicenter, Open-Label, Observational Phase 4 Study to Evaluate Real-World Safety, Tolerability, and Treatment Patterns of Pegcetacoplan (Syfovre) in Patients With Geographic Atrophy Secondary to Age-Related Macular Degeneration

Part of paid clinical trials in Bakersfield, California.

Sponsor
Apellis Pharmaceuticals, Inc.
Study ID
NCT06161584
Status
Active Not Recruiting

Conditions

Eligibility Criteria

Sex
ALL
Age
60 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Pegcetacoplan — DRUG
    Administered intravitreally (IVT) in eyes with geographic atrophy (GA)

Study Details

A Prospective, Multicenter, Open-Label, Observational Phase 4 Study to Evaluate Real-World Safety, Tolerability, and Treatment Patterns of Pegcetacoplan (Syfovre) in Patients with Geographic Atrophy Secondary to Age-Related Macular Degeneration

Key Dates

First listed
Dec 8, 2023
Start date
Sep 28, 2023
Status verified
May 2026
Primary completion
Jun 30, 2027
Completion
Jun 30, 2027

Study Design

Enrollment
300 participants (estimated)

Arms

  • Arm: Observation

Primary Outcome Measure

Incidence of ocular AEs in treated eyes overall and according to physician-directed treatment interval based on US prescribing information [ Time Frame: Up to 36 months ]

Locations (34)

FacilityCityStateZIPSite coordinators
California Retina Consultants (01-026)BakersfieldCalifornia93309-
Retina-Vitreous Associates Medical Group (01-020)Beverly HillsCalifornia90211-
Illinois Retina Associates (01-035)FullertonCalifornia92835-
Retinal Consultants Medical Group Inc (01-008)ModestoCalifornia95356-
Retina Consultants San Diego Inc. (01-018)PowayCalifornia92064-
California Retina Consultants (01-027)Santa BarbaraCalifornia93103-
Bay Area Retina Associates (01-005)Walnut CreekCalifornia94598-
Colorado Retina Associates, PLLC (01-011)LakewoodColorado80228-
Retina Specialty Institute (01-019)PensacolaFlorida32503-
South East Retina Center, PC (01-030)AugustaGeorgia30909-
Georgia Retina (01-032)MariettaGeorgia30060-
Illinois Retina Associates (01-037)Oak ParkIllinois60304-
The Retina Care Center (01-023)BaltimoreMaryland21209-
Cumberland Valley Retina Consultants, P.C. (01-002)HagerstownMaryland21740-
Mid Atlantic Retina Specialist (01-029)HagerstownMaryland21740-
Retina Consultants of Minnesota, PLLC (01-025)EdinaMinnesota55435-
Mid Atlantic Retina (01-031)Cherry HillNew Jersey08906-
Mid Atlantic Retina Research (01-014)Cherry HillNew Jersey08034-
OCLI Research Department (01-007)OceansideNew York11572-
Long Island Vitreoretinal Consultants (01-013)WestburyNew York11590-
Western Carolina Retinal Associates, PA (01-009)AshevilleNorth Carolina28803-
Retina Associates of Cleveland, Inc. (01-017)ClevelandOhio44122-
Retina Associates of Cleveland, Inc. (01-022)ClevelandOhio44130-
Retina Associates of Cleveland, Inc. (01-016)YoungstownOhio44505-
Mid Atlantic Retina (01-001)BethlehemPennsylvania18017-
The Retina Care Center (01-034) - Satellite SiteYorkPennsylvania17402-
Black Hills Regional Eye Institute (01-010)Rapid CitySouth Dakota57701-
Tennessee Retina (01-033)NashvilleTennessee37203-
Integrated Clinical Research (01-024)AbileneTexas79606-
Retina Consultants of Texas (01-004)BellaireTexas77401-
Texas Retina Associates (01-028)DallasTexas75231-
Retina Consultants of Texas (01-003)The WoodlandsTexas77384-
The Retina Group of Washington (01-021)FairfaxVirginia22031-
Pacific Northwest Retina (01-036)BellevueWashington98004-

Find similar trials in Bakersfield, CA

By condition
Age-related macular degeneration
By specialty
OphthalmologyRetina
By research site
California Retina Consultants (01-026)· Bakersfield, CARetina-Vitreous Associates Medical Group (01-020)· Beverly Hills, CAIllinois Retina Associates (01-035)· Fullerton, CARetinal Consultants Medical Group Inc (01-008)· Modesto, CARetina Consultants San Diego Inc. (01-018)· Poway, CACalifornia Retina Consultants (01-027)· Santa Barbara, CA

Related Studies